Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02620683 · ClinicalTrials.gov registry record · NA
Clinical Outcomes of Buffered vs. Non-Buffered Lidocaine
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT02620683 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 23 participants.
The verdict
NCT02620683, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
Anecdotal reports suggest buffering lidocaine with epinephrine just before intraoral injection reduces time of onset, results in a deeper anesthetic effect, without the "sting" with injection from a low pH. Additional data are needed to establish clinical important outcomes such as the peak blood level of lidocaine as compared to the non-buffered drug combination. Clinical pilot studies are proposed as the start of a series of investigations to support or modify the use of the buffered anesthetic for intraoral procedures.
Interventions
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02620683
The ClinicalTrials.gov registry entry for NCT02620683 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine is the first listed.
NCT02620683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02620683 about?
NCT02620683 is a clinical study titled "Clinical Outcomes of Buffered vs. Non-Buffered Lidocaine". Anecdotal reports suggest buffering lidocaine with epinephrine just before intraoral injection reduces time of onset, results in a deeper anesthetic effect, without the "sting" with injection from a low pH. Additional data are needed to establish clinical important outcomes such as the peak blood le...
What is the current status of trial NCT02620683?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02620683?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02620683?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.